Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€48.10

€48.10

0.820%
0.39
0.820%
€78.59

€78.59

 
16:15 / Tradegate WKN: 896133 / Symbol: INCY / Name: Incyte / Stock / Biotechnology & Medical Research / Large Cap /
Latest predictions
€78.59
24.04.24
0.21%
buy
10.04.24
-5.87%
€74.75
23.02.24
-15.11%
buy
€75.48
14.02.24
-10.89%
buy
€78.42
14.02.24
-11.81%
buy
06.02.24
-11.25%
buy
Your prediction

Incyte Corp. Stock

The Incyte Corp. stock is trending slightly upwards today, with an increase of €0.39 (0.820%) compared to yesterday's price.
With 10 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 78 € shows a very positive potential of 62.16% compared to the current price of 48.1 € for Incyte Corp..
For the coming years our community has positive and negative things to say abot the Incyte Corp. stock. Criterium "EBIT growth" gathered the most positive votes but regarding "Customer and product portfolio" there were negative voices in the community.

Pros and Cons of Incyte Corp. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Incyte Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Incyte Corp. 0.820% -3.849% -10.015% -29.982% -15.915% -32.537% -27.613%
Exact Sciences 1.920% -8.132% -4.464% -5.469% -20.050% -50.506% -34.936%
Regeneron Pharmaceuticals Inc. -0.510% -1.120% -6.562% 15.386% 4.100% 105.699% 165.070%
Amgen Inc. 0.340% 1.742% -3.106% 12.422% -3.626% 18.244% 55.511%

Comments

Prediction Buy
Perf. (%) 0.21%
Target price 78.590
Change
Ends at 24.04.25

Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $92.00 to $84.00. They now have an "outperform" rating on the stock.
Ratings data for INCY provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -15.11%
Target price 74.755
Change
Ends at 23.02.25

Incyte Co. (NASDAQ: INCY) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $81.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -10.89%
Target price 75.484
Change
Ends at 14.02.25

Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Citigroup Inc. from $82.00 to $81.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Show more